ERKNet

The European Rare Kidney Disease Reference Network

  

Journal Watch

Immune glomerulopathies

Membranous glomerulonephritis: a step forward in B-cell targeting therapy?
Author(s): Dahan K, Boffa JJ
Source: Nephrol Dial Transplant 2019 Aug 4;
Publication date: 2019-08-4
Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy.
Author(s): Park S, Kim HW, Park JT, Chang TI, Kang EW, Ryu DR, Yoo TH, Chin HJ, Jeong HJ, Kang SW, Lim BJ, Han SH
Source: Nephrol Dial Transplant 2019 Aug 3;
Publication date: 2019-08-3
Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
Author(s): Zhang X, Xie X, Shi S, Liu L, Lv J, Zhang H
Source: Nephrol Dial Transplant 2019 Aug 3;
Publication date: 2019-08-3
Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome.
Author(s): Colucci M, Carsetti R, Rosado MM, Cascioli S, Bruschi M, Candiano G, Corpetti G, Giardino L, Serafinelli J, Giannone C, Ghiggeri GM, Rastaldi MP, Sitia R, Emma F, Vivarelli M
Source: Kidney Int 2019 May 7;
Publication date: 2019-05-7
T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach.
Author(s): Martinez Valenzuela L, Bordignon Draibe J, Fulladosa Oliveras X, Bestard Matamoros O, Cruzado Garrit JM, Torras Ambrós J
Source: Clin Kidney J 2019 Aug;12(4):503-511
Publication date: 2019-08
+ Show 176 more...



European Reference Networks
ERKNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit http://ec.europa.eu/health/ern